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1. Introduction 
The documentation of interventions by hospital pharmacists has been on-going for over 
three decades through various available means; with recent national surveys suggesting that 
the majority of hospital pharmacists continue to document their interventions on a daily 
basis.1-5 Pharmacist intervention encompasses all activities relating to safe medication 
utilisation and optimising therapeutic outcomes for patients in conjunction with other 
health care professionals which ultimately improves patient management or therapy’.5’6 
The percentage of hospital pharmacists documenting and collecting data on a regular basis 
has been shown to vary from as high as 72% to 50% in various countries.1-5 The specialty of 
individual pharmacist’s clinical practice does not seem to significantly influence the number 
of documentation of interventions with 86% of intensive care pharmacists and 74% of 
various clinical specialties reported documenting their interventions on a daily basis.5 
However, there seems to be significant differences in the number of documented interventions 
between clinical pharmacists with respect to the level of managerial responsibilities.5,7 Clinical 
pharmacists with managerial responsibilities have variable workloads, while those without 
have more time allocated to spend on rounds with the medical team, enabling them to 
document all of their interventions. In addition, the significant effect of education level of 
clinical pharmacists and the number of interventions documented has been previously 
published.7 Clinical pharmacists with postgraduate qualifications seem to document 
significantly more interventions than those without.7 This is not surprising that post doctorate 
pharmacists contribute more interventions due to their higher level of training, experience and 
confidence than those without a post graduate degree. 
Various guidelines and suggestions, including recommendations made by the professional 
regulatory bodies have been published on pharmacists' interventions. The American Society of 
Health-System Pharmacist (ASHP) has recommended that, as integral members of the health 
care team, pharmacist must document the care they provide.8 The Practice and Quality 
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Improvement Directorate of the Royal Pharmaceutical Society (RPS)  has provided guidance 
on when an intervention is of sufficient significance for it to be recorded; the contents of the 
records made; where the record should be made; how the records could be utilised to improve 
efficiency and safety; and the length of time the records need to be retained for.9  
2. Benefits and outcomes of pharmacists’ interventions 
Various reasons have been given for the recording of interventions by the RPS; to ensure 
patient safety and improve the quality and continuity of care; to provide evidence of the 
additional value of the pharmacist professional input; to have an accurate record available 
for scrutiny where decisions could be challenged; and to provide an incident or near miss 
monitoring process as part of the an organisation's clinical governance framework. The RPS 
recommends that interventions should be made as soon as possible after the event has 
occurred as this would enable the recording of details to be more accurate. Further 
recommendations include the recording of interventions into the patient’s medication 
records either manually or electronically and they should be used to ensure consistency and 
continuity of standards and for reflective learning within the pharmacy team. 9  
The benefits of pharmacists' interventions in improving patient care is already well 
established, with no evidence of harm done to the patients.10 The contribution made by 
pharmacists have not gone unnoticed and as a result was recognized as essential aspect in 
safe medication use. The close collaboration with the physician through participation in 
medical rounds has been suggested to improve medication safety and has been described as 
important.10 As a result, traditional dispensing part of the hospital clinical pharmacist’s job 
has all but disappeared and has undergone a paradigm shift by working directly with 
patients through the multidisciplinary teams consisting of physicians, nurses and other 
allied health professionals. 
The outcome of pharmacists interventions have led to a reduction in mortality rates, drug 
costs and length of hospital stay.11-13 In addition, it has resulted in improvements in 
medication appropriateness, pharmacoeconomics, health-related quality of life, and patient 
satisfaction.14-17 Furthermore, these interventions have significantly reduced the number of 
drug interactions, medication errors, and adverse drug events. 19-23 
The benefits of pharmacists’ intervention have been exploited for the expansion of the 
clinical pharmacists scope of practice.14 New pharmacy positions such as technicians have 
been created to fill in for the technical duties of pharmacists as a result of the expanded role 
of clinical pharmacists.14 The end result has been a reported lower medication error rate as 
the number of clinical pharmacists increased per occupied bed.15 
There are, however, discrepancies between consensus recommendations of intervention 
recording and documentation of such interventions.18 For this reason, various guidelines7-9 
and suggestions have been published on the subject as outlined above. The controversy of 
whether near miss or other interventions that prevent significant harm to patients by 
hospital pharmacist should be documented in patients' hospital health records when 
making recommendations will not be discussed in this chapter. Since the majority of 
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hospitals have separate reporting systems under risk managements for near misses and 
adverse drug reactions this will be not be reviewed  in this chapter rather pharmacy stand-
alone systems for documentation purpose will be reviewed as this is the most popular way 
for documenting pharmacist interventions. 
3. Methods of pharmacy interventions documentation - A global look 
Various methods of documenting pharmacist interventions have been explored.24-27 Earlier 
systems of documentation interventions used manual recording on a paper-based form and 
later on moved to electronic versions when they became available. Interestingly, the paper 
based intervention documentation system is still the preferred system of documenting of 
pharmacist interventions in some countries as shown by the survey of New Zealand 
Hospitals in 2008 where 88% collected data on paper, the majority using pre-printed 
forms and some using notebooks. In other countries paper based intervention 
documentation system has been replaced by other systems, as shown in a survey of 433 
US health Care centres where only 24% documented interventions manually on a paper 
form.  
 
Figure 1. Paper based system for documenting pharmacist interventions.18  
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Nearly all of the pharmacist intervention documentations systems for recording pharmacist 
interventions are mostly designed in-house to meet the requirements of individual 
hospital’s administrative data requirement. As a result, the pharmacist intervention 
documentation system varies from institution to institution due to different priorities of 
each individual institution as illustrated in tables 1 and 2 where surveys from two different 
countries suggest different priorities of the different institutions.3,5  
 
Type of intervention  
% Respondents 
Documenting 
Change/clarify medication order 92 
Therapeutic duplication 84 
Drug-drug interaction 81 
Adverse drug reaction 76 
Formulary conversion 75 
Medication selection recommendation 73 
Pharmacokinetic consult 73 
Therapeutic substitution 68 
Medication error 67 
Drug or lab level 62 
Drug-food interaction 58 
Drug information response 57 
Potential adverse drug event 57 
Patient education 45 
Parenteral nutrition consult 44 
Drug-disease interaction 44 
Disease management recommendation 43 
Drug use guidelines 40 
Medication use without indication 31 
Drug-herbal interaction 26 
Untreated indication for medication 20 
Pharmaceutical care plan 19 
Admission medication history 15 
Attendance at medical rounds 12 
Patient medical history 11 
CPR response  10 
Discharge plan 9 
Other  5 
Table 1. Type of pharmacist Interventions Documented in US health-systems pharmacy directors 
survey (n=433). 5 
In a survey of US health-systems pharmacy directors,5 the most common type of 
intervention documented were changing or clarifying medication order, therapeutic 
duplication and drug-drug interactions. Adverse drug reactions, formulary selection, 
medication selection and pharmacokinetic consultation were also frequently reported. Less 
frequently reported interventions were pharmaceutical care plans, Admission medication 
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history and patient medication history. Whereas the survey from New Zealand,3 free text of 
the intervention description was frequently reported in addition to the pharmacist 
identification. Less frequent documented interventions was cost savings and time spent on 
interventions.  
 
Type of data  Number of hospitals   
 collecting this data n (%) 
Date of intervention  23 (96%) 
Pharmacist’s name/identification  21 (88%) 
Place where intervention was made  21 (88%) 
Classification of intervention  21 (88%) 
Medication name  21 (88%) 
Brief description of intervention (free text area)  21 (88%) 
Patient NHI/identification  18 (75%) 
Consultant name/identification  18 (75%) 
Reason for making the intervention  15 (63%) 
Severity/ranking of intervention  15 (63%) 
Intervention accepted or declined by other health professional  13 (54%) 
Time spent on intervention  12 (50%) 
Effect on cost saving  8 (33%) 
Drug class/therapeutic classification  6 (25%) 
Table 2. Types of data collected by hospital pharmacies in the survey of New Zealand Hospitals. 3  
4. Challenges and drawbacks of current systems 
The prevalence of in-house documentation systems has been the most significant drawback 
in terms of standardising and achieving consistency of recording of pharmacist 
interventions and eventually using the data as a bench mark for comparison of clinical 
pharmacist’s contributions. This lack of standardisation of pharmacist intervention 
documentation has been the subject of much debate in the literature3,5,18,28 and some have 
proposed to have a standard classification system like the one prevalent for Adverse Drug 
Reaction template imposed by the regulatory authorities.3,5 This would  make it much easier 
to collect meaningful statistics and comparisons be made with other centres as a bench mark 
for clinical pharmacy services.28  
In a survey of US health-systems pharmacy directors, 61% of the respondents reported 
dissatisfaction with their current documentation systems.5 Similar in the survey of New 
Zealand hospitals a large proportion of respondent believed that they had problems with 
their documentation systems.3 Some have suggested that collecting data on paper was very 
time consuming especially if transcribing the data to an electronic storage data base and 
proved difficult to document all interventions. Others have reported that collecting data on 
pre-printed forms was cumbersome and transcribing the data was time consuming.27 
Furthermore, it was difficult to precisely audit pharmacists’ workload, determine the quality 
of interventions and calculate cost saving, in line with what others have reported.24-28  
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With the difficulties encountered with the paper based pharmaceutical care intervention 
form, the challenges faced by any administrator is to implement a system that is user 
friendly and capture the data that is required. Another challenge is to capture all 
information that was previously entered on paper, increase the data-entry speed, and 
modify the database to address specific needs that was identified by the end users. One 
major advantage of an electronic system is the ease with which it facilitates monthly and 
annual reporting for departmental quality assurance programs. Numerous articles have 
been published on electronic pharmacist intervention programs in the literature and most 
have focused on a main frame computer terminal based in the pharmacy department. 24-28 
5. The King Faisal Specialist Hospital’s experience, a personal-
perspective 
We had faced similar problems with our paper based documentation systems as described 
above, and in an attempt to improve the documentation of pharmacist’s intervention we 
successfully developed and implemented a computerised application program to facilitate 
the collection and analysis of the data. Prior to this, pharmaceutical care activities and 
clinical interventions were either not documented or inconsistently documented (see figure 
2). Later, the multi-user PC version and the subsequent enhanced version, the web based 
application revealed an increase in the number of interventions done by individual 
pharmacist with more pharmacists participating in the interventions recording regularly. 
We were able to show that by keeping the intervention program simple and easy to use; the 
contributions of individuals not only increased but were consistent. Here we describe in 
detail how we managed to develop our in-house documentation systems which may assist 
others in making similar documentation systems.  
 
Figure 2. Clinical Pharmacist’ interventions showing the trend from the paper based in 1997 to the 
multiuser PC (2004-2005) and finally up to the introduction of the web-based systems (2006-2007)- 
Unpublished Data (experience from KFSH&RC). 
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6. Process of documentation 
6.1. The software 
Traditionally two main types of electronic system of documenting of pharmacists 
interventions have been available to pharmacists for documentations of their interventions. 
One is the computer based pharmacist intervention program, multi-user PC version, 
restricted to a single point of entry in the pharmacy department or on the wards and the 
other a web based program such as based on Microsoft Visual Fox Pro® program Multi-user 
Application running under the Citrix® server using any terminal equipped with a Citrix® 
client. 
 
Figure 3. Main screen of the multi-user PC software intervention form. Only one outcome could be 
documented at a time by the clinical pharmacist. 7 
The multi-user PC version provides a platform for easy manipulation, customization, and 
updating the paper based program. It allows the mangers to monitor performance of 
individual pharmacists by evaluating the number of interventions made and the acceptance 
for daily interventions. In addition, it provides reports for the hospital administration on 
clinical pharmacists' activities and the data generated can be used to justify additional 
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clinical pharmacists' positions. However, the system requires installation of the software in 
individual stand-alone personal computers (PCs). With the limited numbers of PCs that 
could be accessed by the pharmacists at the point of need e.g. during the physician rounds 
and within the pharmacy department most often the clinical pharmacists have to record the 
interventions manually on paper intervention form on the physician rounds and later on 
record their interventions on the multi-user PC version, resulting in incomplete data 
collection and duplication of work which was time consuming. 
From our experience,7, 18-19 the web based program of pharmacists’ documentation systems 
facilitates ease of access and improves overall accuracy in data entry. The web based system 
enables the pharmacist to enter interventions from any workspace, in the clinic; on the ward; 
in the inpatient and outpatient dispensary. This may be achieved using any PC, laptop or 
even wireless personal digital assistant (PDA) connected to the hospital intranet. The ability 
to access the intervention program from any point is one major advantage of the web based 
intervention program. The web based application had one big advantage over the multi-
user PC version since installation was not required in every PC and the program could be 
accessed from any location with intranet access. Since all in- patient areas and clinics were 
connected to the intranet, the easy access enabled the pharmacist to enter interventions from 
any workstation, in the clinics and on the ward during the physician rounds. This has been 
reflected in our recent study,7 where the use of the web-based application revealed a 40% 
increase in the total number of documented interventions compared to multi-user PC 
software. In addition the time required to document an intervention using the web-based 
application of 66.55 ± 8.98 s (mean ± SD), is  much quicker than documenting on paper base 
forms and as others have previously reported time of 81.8 ± 8.3 for web based program.7,29 
As the majority of dissatisfaction with the pharmacy documentations systems was reported 
to be a lack of time the lack of pharmacist time,3, 5 the clinical pharmacist documentation 
system must be as efficient, and user-friendly as possible to be fully accepted by the end 
users and hence, be successfully implemented. 
6.2. Intervention entry 
Figure 4 depicts the “main intervention form” with the major categories e.g. Type of 
Intervention; Clinical Significance; Drug Related Problem; Acceptance; Expected Outcome 
clearly highlighted. It allows for the identification of the patient through the patient Medical 
Record Number (MRN), as well as the date and the location of the intervention. The 
pharmacist documenting the intervention is identifiable through the Drop-down 
pharmacists list which is password protected. The form further allows the pharmacist to 
document the main types of intervention inclusive of an intervention summary and the 
pharmacist recommendation. The web based program further enables the pharmacist to 
document cost saving only interventions on the main intervention form.  
The cost saving interventions includes changes in dosage regimens, substitution with a less 
expensive drug, discontinuation of unnecessary drug and other indirect savings such as 
change form intravenous to oral formulation.  
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Figure 4. Main Data entry screen of the web based documentation application. 7 Data entry screen for 
the patient demographic details of the web-based application with a mixture of drop down menus and 
free-text entry for comments. Free text entry must be kept to a minimum, in order to keep data entry 
simple and to improve the retrieval of information for reporting purposes. Patient’s specific data i.e. 
Medical Record Number (MRN) and the intervention details were entered by free text.  
7. Database construction and use 
Ideally the use of free text entry should be kept to a minimum, in order to keep data entry 
simple and improve retrieval of information for reporting purposes. Patient’s specific data 
i.e. Medical Record Number (MRN) can be entered by free text. The location and the 
intervention date can be entered using the drop down menus and radio buttons. The radio 
buttons are arranged in pre-determined groups of related options on the main data entry 
point based on our pharmaceutical care manual intervention form i.e. basic details, drug 
related problems, type of intervention, clinical significance, acceptance, and expected 
outcomes displayed on a screen as a list. Different types of clinical interventions were 
available under the tab of the type of intervention i.e. pharmacokinetics, 
pharmacotheraputics, drug information, and miscellaneous.  
8. Description of software 
The construction of the database of the web based intervention program must take into 
consideration the feedback of the participating and non participating pharmacists, the 
departmental quality assurance pharmacist and the limitations of the multi-user PC version. 
The database must be designed to be user friendly with a multi-option of radio buttons, 
check boxes, and drop down menus. The free-text entry is to be kept at minimum for the 
descriptive nature of the interventions. The data entry must be user ID and password 
protected and the individual user documenting the intervention should be identifiable 
through their password which requires user authentication.  
8.1. Data entry 
The patients' number and location can be entered as free text. Using tab keys, allows the 
user to switch between different categories of interventions, basic details; drug related 
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problems; type of interventions; clinical significance; acceptance; and expected outcome 
Activating the tab, done by a mouse click, make its associated content visible and the tab 
itself becomes highlighted to distinguish it from other inactive tabs. Only one tab must be 
activated at a time and the user cannot continue to the next step if there was missing details 
in the intervention form. Minimal manual data entry was required for documentations of 
interventions, with only the detail of the interventions done by free text.  
 
Figure 5. Data-entry screen for drug related problems of the web based documentation application. 7 
The user selects the type of intervention using radio buttons and only one selection could be activated at 
a time. The selection of a radio button is done by clicking the mouse on the button, or the caption, or by 
using a keyboard shortcut. It was not possible to leave any of the radio buttons in a group unselected, as 
the user would not be allowed to move to the next screen.  
8.2. Validation of pharmacy intervention documentation 
The reliability and validity of pharmacist intervention data documented has been 
questioned by some and have highlighted the lack of consistency in categorising 
interventions.18 The lack of reliability in the individual pharmacist coding of interventions 
should be of concern especially if there is a lack of the reliability of the data generated. In 
order to standardise the intervention data, we defined three main types of interventions, 
which was highlighted when the user placed the cursor on the icon; Potentially Severe / 
High was defined as an intervention that may have resulted in decreasing patient mortality, 
preventing or reducing organ damage or system failure, and resulted in cost savings; 
Important / Moderate intervention was defined as an intervention that may have resulted in 
improving the quality of patient care; and Minor / Low interventions was defined as an 
intervention that may have resulted in improving convenience of compliance. This allowed 
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the user to enter the correct category as the definitions of the interventions were readily 
available (figure 6). 
 
Figure 6. Data-entry screen for clinical significance of the web based documentation application. 7 
The cursor highlights the definition of the intervention when it is placed on the icon, thereby ensuring 
consistency in the data that is collected.  
8.3. Documentation of cost savings 
Inaccurate cost savings projections and the difficulty in making accurate cost savings 
projections have been cited as one of the major shortcomings in pharmacist intervention 
documentation systems in the surveys of US health systems pharmacy directors and New 
Zealand hospital pharmacies. In these surveys only 27% of US health-systems pharmacists 
and 33% of New Zealand pharmacists documented cost savings interventions. Although 
cost saving interventions was not specifically mentioned in the recommendations posted by 
the professional or regulatory bodies on documenting pharmacist interventions, they easily 
justify their inclusion in the clinical pharmacist’s documentation system. In addition to 
justifying the hiring of additional clinical pharmacists, cost savings information helps 
emphasize the critical role of pharmacy in managing hospital drug budgets. These costs 
have risen dramatically in the recent years and continue to climb, which has resulted in 
pressure from hospital administrators to contain these costs. Taken together, consideration 
of the cost savings that result from clinical pharmacist interventions is an important factor in 
modern clinical practice. With the ever increasing cost of medications and pressure from 
hospital administrators, the impact of clinical pharmacist on cost savings could be 
emphasised to the senior hospital administrators.23  
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Figure 7. Data-entry screens for cost savings of the web-based documentation application. 7 After the user 
selects the cost saving, specific data fields are made available that allow for the accurate reporting of cost 
savings using the software. The medications are pre-populated in the application. The software allows for 
cumulative cost savings to be calculated at the end of each financial year for each individual pharmacist.  
However, the documented cost savings on drugs represent only a fraction of total cost 
savings as other indirect cost savings such as decreased hospital length of stay, reduction in 
the pharmacy and/or nursing time (e.g. switching from IV to oral medications) was not 
captured by our intervention program. Nevertheless, the significant sums of money 
involved are a justification for its inclusion in the pharmacist intervention program which 
was not included in the RPSGB guidance on recording of interventions. Cost savings 
interventions made by the pharmacists can be used to justify additional clinical pharmacist 
positions while emphasising the role played by the pharmacy department in managing the 
hospital drugs budget with the hospital administration. 
9. How to use these records 
The ease with which monthly or periodical reports are generated is one advantage of the 
web-based system. The system enables one to run monthly or periodical statistics on all 
interventions entered in the system. The generation of the clinical intervention reports may 
be utilised by the departmental managers during the annual staff appraisal and more 
importantly in the departmental quality assurance programs. The monthly or the periodical 
reports generated further ensure consistency and continuity in interventions standards. 
Moreover, junior pharmacists and pharmacy residents working in the department can 
utilise the data as a technical aid for documenting interventions. The underutilisation of the 
reports generated has been routinely mentioned by most hospitals and some have suggested 
that the reports must be shared with the medical and nursing staff through the various 
committees such as drug utilisation committee, quality improvement committee, senior 
hospital management and pharmacy and therapeutics committee.5  
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 Multiuser PC software Web-based 
application 
Drug Related Problems Number Percentage Number Percentage 
No Indication for drug therapy
No order for medical condition 
Inappropriate drug selection 
Inappropriate dosage regimen 
Prescribed drug not administered 
Potential/Actual  (ADR/Allergy/Toxicity)
Potential/Actual Drug Interaction (DI) 
Miscellaneous 
Not Documented*
245
295 
113 
1326 
2 
211 
46 
1988 
700
4.97
5.99 
2.29 
26.92 
0.04 
4.28 
0.93 
40.36 
14.21
523
642 
256 
1756 
8 
518 
517 
2536 
0
7.65 
9.39 
3.74 
25.67 
0.12 
7.57 
7.56 
37.08 
0 
Type of Intervention Number Percentage Number Percentage 
Pharmacokinetics
Pharmacotherapeutics 
Drug Information 
Miscellaneous 
Not Documented*
1273
2483 
775 
203 
192
25.84
50.41 
15.73 
4.12 
3.90
1250
5341 
157 
92 
0
18.27 
78.08 
2.30 
1.35 
0 
Clinical Significance Number Percentage Number Percentage 
Potentially Severe / High
Important / Moderate 
Minor / Low 
Not Documented
337
3186 
449 
954
6.84
64.68 
9.11 
19.37
830
5495 
515 
0
12.13 
80.34 
7.53 
0 
Acceptance Number Percentage Number Percentage 
Accepted 
Modified then accepted 
Denied 
Unknown 
Not Documented*
4398
144 
135 
114 
135
89.28
2.92 
2.74 
2.31 
2.74
6288
178 
150 
224 
0
91.93 
2.60 
2.19 
3.27 
0 
Expected Outcome Number Percentage Number Percentage 
Cost Saving 
- D/C unnecessary drug 
- Change dosage regimen 
- Change to less expensive drug 
- Indirect cost saving
234
344 
129 
13 
23
4.75
6.98 
2.62 
0.26 
0.47
1988
1208 
547 
109 
124
29.06 
61.44 
27.82 
5.54 
6.23 
Enhanced therapeutic effect
ADR / Toxicity prevented / resolved 
Not Documented*
1581
2197 
405
32.10
44.60 
8.22
3163
2628 
0
46.24 
38.42 
0 
Interventions cost savings 132,937.99 SR
($35,347.00)
228,786.93 SR 
($61,000.00) 
Total Interventions 4926 6840 
*The web-based application does not allow users to continue to the next screen unless all fields are completed thereby 
ensuring completeness and accuracy of the data collected.  
Table 3. Clinical Interventions Report. 7 Percentages are based upon the total number of interventions.  
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9.1. The use of mobile devices in clinical pharmacy documentation 
The utilization of informatics and information technology in health care systems in the 
developed country is a common practice nowadays. This has ranged from informatics 
systems used for direct patient care to documentation of this care to those for billing and 
coding requirements. Mobile Personal Digital Assistants (PDAs) and now Smart Phones 
(SPs) and Tablet computers (TCs) e.g iPads, have the capability, power and technology 
needed to run such informatics systems for health care professionals who are in constant 
need for instant communication. Previous studies have outlined the usefulness of these 
mobile devices in data collection and documentation of clinical activity by health care 
providers.5,35-38 Currently used methods of documentation depend on standalone systems 
that are usually equipped with online access capability. Many hospitals in North America 
and Europe use online documentation forms hosted on their intranet that can be accessed 
via mobile devices equipped with wireless or cellular (3G or 4G) connectivity. The 
hypothesis is that this will facilitate access and eventually improve documentation.35-38  
There are different platforms of mobile devices which employ similar applications from 
different manufacturers. Main platforms available in the market up until the writing of this 
chapter include those from Google, Inc. (Android based), Apple, Inc. (IOS based), Research 
in Motion (RIM), Inc. (BlackBerry based), and Microsoft, Inc. (Windows Phone based).  
There has been an increased utilization of this technology for documenting pharmacists’ 
interventions over the last few years. An earlier study in 2003 found that only 15% of 
surveyed hospitals used computerized tools for pharmacists’ interventions documentation 
and only 5% of those hospitals used a mobile device technology.5 Other reports have shown 
a rapid increase in adopting this technology. Another study showed up to 54% of pharmacy 
interventions in a single hospital were recorded via mobile devices.38 
Advantages of using mobile devices in documenting pharmacists’ interventions include 
more flexibility, speed and completeness. One study evaluated the completeness and speed 
of documentation using mobile devices compared to manual method and found out that 
captured fields of a single documentation was 96% vs. 86% in PDAs technology and 
traditional paper method; respectively.38 More interventions were recorded in 3-10 minutes 
in the PDAs group compared to traditional paper method. The study concluded that the use 
of PDA technology was more complete and efficient that the traditional method.38  
There are several challenges for implementation and adoption of mobile devices for 
documentation purposes. These include but are not limited to cost of implementation and 
maintenance, security of transmission, and acceptance by pharmacy practitioners. Cost of 
such electronic means of documentation includes hardware, software, maintenance fees and 
pharmacist time. In one report, the annual cost of maintaining such system was up to US 
5,000 not including pharmacist time.5 
Securing the confidentiality of transmitting patient sensitive data is of paramount 
importance and this has been a challenge to most hospitals. Several developed countries 
have legislation in existence that mandate protection of patient personal information. Both 
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Canada and the United States have passed the Personal Information Protection and 
Electronic Documents Act and the Health Insurance Portability and Accountability Act 
(HIPAA); respectively. Both require certain measures to ensure that only authorized users 
can access these devices/systems. It is recommended that data encryption and access control 
be implemented to protect patient information stored on these systems.39-40   
9.1.1. Personal perspective 
Our successful experience with the implementation of the web based system of monitoring 
pharmacist interventions has led us to move forward to adopt a more easily accessible 
electronic documentation method; Mobile devices. Our plan, unlike previously reported 
methods is to focus on utilizing an online documentation application hosted on our intranet 
that can be accessed via mobile devices equipped with wireless connectivity. We 
hypothesize that this will facilitate access and eventually improve documentation.  
We also plan to develop an Android and iOS based applications that will be installed on 
variety of mobile devices (Android phones and tablets and iPhones and iPads). This will allow 
users to enter data in both passive mode (off-line) and active (on-Line) modes. Currently, all of 
our hospital facilities are equipped with wireless hotspots (WiFi 802.11n standard) that provide 
100% wireless coverage. The currently used online software will be re-written with web 
support to suite mobile devices. We plan to have a real-time synchronization with the clinical 
intervention server hosted in our Information Technology (IT) department. We also plan to 
have the client installed on the Smart Phones and iPads to manually synchronize with the 
server once the devices connects to our intranet. This will allow clinicians to manually 
synchronize data in case of unavailability of wireless coverage.  
9.2. Pharmacy data mining 
Data mining in pharmacy encompasses many functions which utilize technology that gives 
pharmacists the ability to analyse the huge amount of data related to drugs and their 
clinical. By definition these functions allow pharmacists to convert the raw data into 
meaningful information to guide best decision making.41 In the near past, pharmacy 
computer systems were standalone and closed by design. They were not integrated with 
other health information systems that contain important patient data e.g. laboratory, 
pathology, radiology, nursing and physician documentations. Over the last decade, the 
concept of having an integrated clinical information system has been adopted by many 
health care systems. This has led to an enormous increase in the amount and complexity of 
data that necessitated a sophisticated data warehouse or data repository. The clinical data 
repository collects, organizes and integrates pieces of data into what is known as data cubes 
or data marts. In pharmacy, these data cubes contain patient demographics, medication 
orders, physicians’ and nurses’ notes, laboratory results, and pharmacy interventions.41 
Because of the nature and complexity of pharmacy data, clinical repositories need to be 
“mined” in a systematic and logical manner. To achieve the best results, these data 
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warehouses need to be secure, easily accessible, able to capture historical and real-time data, 
and capable of capturing population specific data to allow identification of management and 
clinically oriented trends for the pharmacy department and the whole organization. Once 
fully integrated, the benefits of clinical repositories extend to include enhanced 
communication between care-givers, and improved daily patient care.  
Several clinical repository tools exist in the market. These include but are not limited to 
MicroStrategies (http://www.microstrategy.com/), Cognos (http://www.cognos.com/), 
Business Objects (http://www.businessobjects.com/) and Brio Technology 
(http://www.brio.com/). These tools are designed to enable directors of pharmacy, clinical 
pharmacy coordinators and other pharmacy informatics specialists to populate and analyse 
the raw data to yield meaningful clinical and managerial information to guide day to day 
operation in addition to other strategic decisions.41 
Over the past few years, mining pharmacy data to monitor prescribing patterns and 
enhance revenues of insurance companies has been widely utilized in the United States. It is 
estimated that one billion prescriptions per year is being mined in the US alone based on 
one report2. More than 51,000 retail pharmacies in the United States participate in data 
mining through 2 major data mining companies. This has resulted in significant revenues to 
the data miners that exceed $2 billion annually.42 Despite the clear value of mining 
pharmacy data (clinically and financially), there has been some controversy over the past 
few years on the legality of pharmacy data mining.42,43 Despite that data miners remove 
patient identifiers, several states have banned pharmacy data mining because of claims that 
it invades prescribers’ privacy and that it violates the Health Insurance Portability and 
Accountability Act (HIPAA). Several lower courts have ruled that pharmacy data mining is 
unconstitutional, however, recently the supreme court has decided that it is in fact 
constitutional.42-44  
In early 2000s, we created a data warehouse at our institution as one of the first 
organizations to do so in the Middle East. We currently utilize IBM Cognos Enterprise as 
our data warehouse and performance management tool. After the successful 
implementation of our Integrated Clinical System (ICIS) in 2010, we planned to design and 
create different pharmacy reports form this data warehouse that include work load statistics 
at the user level, automated score card, Medication Utilization Evaluations (MUEs), turn-
around time for inpatient and outpatient prescriptions and discharge medications, 
prescription trends, and prescription variances.  
10. Summary 
The accurate and precise documentation of interventions should be seen as a barometer of 
pharmacist activities and it is beyond any reasonable doubt that the clinical pharmacy 
documentation in hospitals has made a significant impact not only amongst the hospital 
administrators but also amongst the medical and nursing fraternity. However, there is still 
room for much improvement of the documentations. Since the recording of clinical 
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pharmacists’ interventions is not mandatory in most of the institutions but it is highly 
recommended with little punitive action for those not recording their interventions. This 
non–punitive policy generally results in only a few dedicated pharmacists’ documenting the 
interventions on a regular basis, whilst others documented infrequently and some do not 
participate at all. Numerous reasons have been cited for the non-participation in the 
recording of interventions and the repetitive nature of the program was the main reason for 
the non-adherence. The majority see as it as a tool for gathering statistics and time 
consuming. However, those institutions that have incorporated the clinical pharmacist 
documentation into the annual evaluations of clinical staff pharmacists have observed an 
increase in the number of interventions documented. This in turn gives the pharmacy 
administration the justification required to approve additional FTEs and/or resources for 
their institutions. In addition, the impact of technology on pharmacist documentation 
program is best described again by the increase in the documentation of clinical pharmacy 
services, resulting in an increase the number of clinical pharmacists. So as long as 
pharmacists keep documenting their interventions and the technology keeps on improving 
through the hand held devices or even through the use of smart phones by making the 
process easier and faster their role as safe custodian of medications usage should be 
enshrined in law.  
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